Search Results

The Browne Rapicide Glutaraldehyde Indicator is a glutaraldehyde concentration monitor dedicated for use with Rapicide® High-Level Disinfectant and Sterilant. The purpose of the Browne Rapicide Glutaraldehyde Indicator is to determine whether the glutaraldehyde concentration of a Rapicide® High-Level Disinfectant and Sterilant solution is above the minimum recommended concentration, allowing the solution to be re-used for reprocessing temperature-sensitive (and other) instruments if the glutaraldehyde concentration is found to be greater than 1.5%.

Device Description

The Browne Rapicide Glutaraldehyde Indicator is a chemical indicator strip consisting of an absorbent paper pad impregnated with the reactive chemicals, which is adhesively bonded to one end of a polymer film. The Browne Rapicide Glutaraldehyde Indicator has been developed to monitor the active glutaraldehyde concentration of Rapicide® High-Level Disinfectant (K993042) and Sterilant solution at 35 °C that has an MRC of 1.5% glutaraldehyde.

AI/ML Overview

The provided text does not contain detailed information about specific acceptance criteria and a structured study demonstrating the device's performance against them. The document is a 510(k) summary for a glutaraldehyde indicator, focusing on its substantial equivalence to a predicate device, intended use, and general product description.

However, based on the intended use described, we can infer the primary performance characteristic that would be subject to acceptance criteria: accuracy in determining if the glutaraldehyde concentration is above 1.5%.

Let's try to extract relevant information and identify what is missing for a complete answer based on your request.

Inferred Acceptance Criteria and Reported Device Performance (Table):

Acceptance Criterion (Inferred from Intended Use)	Reported Device Performance (Based on provided text)
Accurately indicate when glutaraldehyde concentration is ≥ 1.5% (Minimum Recommended Concentration - MRC).	The Browne Rapicide Glutaraldehyde Indicator has been developed to monitor the active glutaraldehyde concentration of Rapicide® High-Level Disinfectant (K993042) and Sterilant solution at 35 °C that has an MRC of 1.5% glutaraldehyde. The purpose of the Browne Rapicide Glutaraldehyde Indicator is to determine whether the glutaraldehyde concentration of a Rapicide® High-Level Disinfectant and Sterilant solution is above the minimum recommended concentration, allowing the solution to be re-used for reprocessing temperature-sensitive (and other) instruments if the glutaraldehyde concentration is found to be greater than 1.5%. Essentially, the claim is made that it performs this function, but the specific data from a study proving this accuracy (e.g., sensitivity, specificity, PPV, NPV) with numerical results is not provided in this document.
Accurately indicate when glutaraldehyde concentration is < 1.5%.	(Inferring the converse of the above) The document implies it would indicate below 1.5% to prevent reuse, but specific performance metrics are not provided.

Acceptance Criterion (Inferred from Intended Use)

Reported Device Performance (Based on provided text)

Accurately indicate when glutaraldehyde concentration is ≥ 1.5% (Minimum Recommended Concentration - MRC).

The Browne Rapicide Glutaraldehyde Indicator has been developed to monitor the active glutaraldehyde concentration of Rapicide® High-Level Disinfectant (K993042) and Sterilant solution at 35 °C that has an MRC of 1.5% glutaraldehyde. The purpose of the Browne Rapicide Glutaraldehyde Indicator is to determine whether the glutaraldehyde concentration of a Rapicide® High-Level Disinfectant and Sterilant solution is above the minimum recommended concentration, allowing the solution to be re-used for reprocessing temperature-sensitive (and other) instruments if the glutaraldehyde concentration is found to be greater than 1.5%. Essentially, the claim is made that it performs this function, but the specific data from a study proving this accuracy (e.g., sensitivity, specificity, PPV, NPV) with numerical results is not provided in this document.

Accurately indicate when glutaraldehyde concentration is < 1.5%.

(Inferring the converse of the above) The document implies it would indicate below 1.5% to prevent reuse, but specific performance metrics are not provided.

Missing Information (Not available in the provided text):

Sample size used for the test set and the data provenance (e.g., country of origin of the data, retrospective or prospective): This document does not provide details on the study's sample size, data provenance, or whether the tests were retrospective or prospective. It only states that the device was "developed to monitor" and its "purpose is to determine."
Number of experts used to establish the ground truth for the test set and the qualifications of those experts: This information is not present. For chemical indicators, the "ground truth" would typically come from analytical chemistry methods (e.g., titration or spectrophotometry) rather than expert human interpretation of the indicator itself.
Adjudication method (e.g., 2+1, 3+1, none) for the test set: Not applicable and not mentioned given the nature of a chemical indicator. The ground truth would be chemical analysis.
If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: This is not applicable to this device. This device is a chemical indicator that produces a color change, not an AI-based diagnostic tool requiring human interpretation improvement studies.
If a standalone (i.e., algorithm only without human-in-the-loop performance) was done: The device is inherently "standalone" in its operation as a chemical indicator, but the performance metrics of this standalone operation are not detailed (e.g., how accurate it is compared to a gold standard chemical test).
The type of ground truth used (expert consensus, pathology, outcomes data, etc.): For a chemical indicator, the ground truth would be established by a quantitative chemical analysis (e.g., titration, spectrophotometry, or other validated analytical methods) of the glutaraldehyde concentration in the solution. This is not explicitly stated but is the standard for such devices.
The sample size for the training set: Not applicable and not mentioned. Chemical indicators are typically designed and tested based on chemical reactions, not "trained" like AI models.
How the ground truth for the training set was established: Not applicable for a chemical indicator. Chemical indicators are developed based on known chemical reactions and their visual manifestation.

Summary of available information regarding the study mentioned and its proof of acceptance criteria:

The document is a 510(k) summary, which focuses on demonstrating "substantial equivalence" to a predicate device rather than providing a detailed technical report of the studies performed. It states:

Study Implication: The device "has been developed to monitor" the glutaraldehyde concentration and its "purpose is to determine whether the glutaraldehyde concentration... is above the minimum recommended concentration." This implies that testing was conducted to ensure it fulfills this purpose.
Proof: The "Description of Safety and Substantial Equivalence" (Section 5) states: "The proposed and predicate devices are all single use indicators used to monitor glutaraldehyde concentration in specific solutions. The differences between the proposed Browne Rapicide Glutaraldehyde Indicator and predicate devices are limited to differences in the device design and materials. These differences do not raise any new issues of safety and efficacy." It also mentions "A summary of the technological characteristics of the new device in comparison to those of the predicate devices is provided in Section 12 of this premarket notification," but Section 12 is not included in the provided text.

Conclusion:

While the document clearly states the intended function of the device (to indicate if glutaraldehyde concentration is > 1.5%), it does not provide the specific performance data, study design, sample sizes, ground truth establishment methods, or expert qualifications that would comprehensively answer your request regarding acceptance criteria and their proof. It focuses on regulatory substantial equivalence rather than a detailed scientific study report.

Ask a Question

Ask a specific question about this device

Page 1 of 1